Share on LinkedInShare on LinkedIn

ARTICLE · 13 DECEMBER 2023

Biden Threatens To Cancel Pharma Patents

The U.S. government is threatening to go after companies who obtained patents on drugs developed with the help of government grants. The administration did not immediately...

United StatesIntellectual Property

The U.S. government is threatening to go after companies who obtained patents on drugs developed with the help of government grants. The administration did not immediately release details about how the process will work and how it will deem a drug costly enough to act. The proposed process would clarify that the drug's patent could be in jeopardy if its price is out of reach for Americans, White House officials said.

Such an action by the government, called "march in rights", has never been taken.

Here are some key points about the proposal:

Motivation: The administration argues that high drug prices are a major burden for Americans and that cancelling patents could promote competition and lower prices. This is in line with Biden's broader campaign promise to address healthcare affordability.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from